| Long name | APOH Primary Polyclonal Antibody |
| Also known as | APOH PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | APOH |
| Specificity | This is a highly specific antibody against APOH |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 310-345/345 |
| Subcellular location | Secreted |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human ApoH |
| Gene ID number | 350 |
| Swiss Prot | P02749 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells, and dextran sulfate, phospholipids, Binds to various kinds of negatively charged substances such as heparin |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | APC inhibitor, APOH, Activated protein C-binding protein, Anticardiolipin cofactor, Apo-H, Apolipoprotein H, B2G1, B2GP1, B2GPI, Beta(2)GPI, Beta-2-glycoprotein 1, Beta-2-glycoprotein I, BG |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | APOH |
| Short name | APOH Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | apolipoprotein H (beta-2-glycoprotein I) (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | APOH and IDBG-643750 and ENSBTAG00000001915 and 281006, APOH and IDBG-65172 and ENSG00000091583 and 350, Apoh and IDBG-213761 and ENSMUSG00000000049 and 11818, B2G1 and B2GP1 and BG, Extracellular, intrinsic pathway and biological process this GO :0008201 and heparin binding and molecular function this GO :0008289 and lipid binding and molecular function this GO :0009986 and cell surface and cellular component this GO :0010596 and negative regulation of endothelial cell migration and biological process this GO :0016525 and negative regulation of angiogenesis and biological process this GO :0030193 and regulation of blood coagulation and biological process this GO :0030194 and positive regulation of blood coagulation and biological process this GO :0030195 and negative regulation of blood coagulation and biological process this GO :0031012 and extracellular matrix and cellular component this GO :0031639 and plasminogen activation and biological process this GO :0033033 and negative regulation of myeloid cell apoptotic process and biological process this GO :0034197 and triglyceride transport and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034392 and negative regulation of smooth muscle cell apoptotic process and biological process this GO :0042627 and chylomicron and cellular component this GO :0042802 and identical protein binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0051006 and positive regulation of lipoprotein lipase activity and biological process this GO :0051917 and regulation of fibrinolysis and biological process this GO :0051918 and negative regulation of fibrinolysis and biological process this GO :0060230 and lipoprotein lipase activator activity and molecular function this GO :0070062 and extracellular vesicular exosome and cellular component, lipoprotein lipase activator activity, this GO :0001937 and negative regulation of endothelial cell proliferation and biological process this GO :0001948 and glycoprotein binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005543 and phospholipid binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0006641 and triglyceride metabolic process and biological process this GO :0007597 and blood coagulation, this GO :0001948: glycoprotein binding, this GO :0001948: glycoprotein binding and also this GO :0005515: protein binding and also this GO :0005543: phospholipid binding and also this GO :0008201: heparin binding and also this GO :0008289: lipid binding and also this GO :0042802: identical protein binding and also this GO :0060230: lipoprotein lipase activator activity, this GO :0005515: protein binding, this GO :0005543: phospholipid binding, this GO :0008201: heparin binding, this GO :0008289: lipid binding, this GO :0042802: identical protein binding, this GO :0060230: lipoprotein lipase activator activity, apolipoprotein H (beta-2-glycoprotein I) |
| Identity | 616 |
| Gene | APOH |
| Long gene name | apolipoprotein H |
| Synonyms gene | B2G1 |
| Synonyms gene name | apolipoprotein H (beta-2-glycoprotein I) |
| Synonyms | BG |
| Synonyms name | beta-2-glycoprotein I |
| Locus | 17q24, 2 |
| Discovery year | 1987-09-11 |
| Entrez gene record | 350 |
| Pubmed identfication | 1582254 |
| RefSeq identity | NM_000042 |
| Classification | Sushi domain containing Apolipoproteins |
| Havana BLAST/BLAT | OTTHUMG00000179530 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue